nach oben

Inflammation

Erschienen in:

06.01.2021 | Review

The Role of α7nAChR-Mediated Cholinergic Anti-inflammatory Pathway in Immune Cells

verfasst von: Yi-jin Wu, Li Wang, Chao-fan Ji, Shao-fei Gu, Qin Yin, Jian Zuo

Erschienen in: Inflammation | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Alpha 7 nicotinic acetylcholine receptor (α7nAChR) is widely distributed in the nervous and non-cholinergic immune systems. It is necessary for the cholinergic transmitter to participate in the regulation of inflammatory response and is the key element of cholinergic anti-inflammatory pathway (CAP). Because of the profound impact of CAP on the immune system, α7nAChR is considered as a potential therapeutic target for the treatment of inflammatory diseases. Available evidences confirmed that manipulation of CAP by activating α7nAChR with either endogenous acetylcholine (ACh) or cholinergic agonists can substantially alleviate inflammatory responses both in vivo and in vitro. However, the mechanism through which CAP curbs the excessive pro-inflammatory responses and maintains immune homeostasis is not fully understood. Obtained clues suggest that the crosstalk between CAP and classical inflammatory pathways is the key to elucidate the anti-inflammatory mechanism, and the impacts of CAP activation in α7nAChR-expressing immune cells are the foundation of the immunoregulatory property. In this article, we review and update the knowledge concerning the progresses of α7nAChR-based CAP, including α7nAChR properties, signal transductions, interactions with classic immune pathways, and immunoregulatory functions in different immune cells. Certain critical issues to be addressed are also highlighted. By providing a panoramic view of α7nAChR, the summarized evidences will pave the way for the development of novel anti-inflammatory reagents and strategy and inspire further researches.

Czura, C.J., S.G. Friedman, and K.J. Tracey. 2003. Neural inhibition of inflammation: the cholinergic anti-inflammatory pathway. Journal of Endotoxin Research 9 (6): 409–413.PubMedCrossRef

Pavlov, V.A., and K.J. Tracey. 2004. Neural regulators of innate immune responses and inflammation. Cellular and Molecular Life Sciences 61 (18): 2322–2331.PubMedCrossRef

Czura, C.J., and K.J. Tracey. 2005. Autonomic neural regulation of immunity. Journal of Internal Medicine 257 (2): 156–166.PubMedCrossRef

Wei, W. 2016. Soft regulation of inflammatory immune response. Chinese Pharmacological Bulletin 32 (3): 297–303.

Rosas-Ballina, M., and K.J. Tracey. 2009. Cholinergic control of inflammation. Journal of Internal Medicine 265 (6): 663–679.PubMedPubMedCentralCrossRef

Qian, Y.S., Q.Y. Zhao, S.J. Zhang, Y.J. Zhang, Y.C. Wang, H.Y. Zhao, Z.X. Dai, Y.H. Tang, X. Wang, T. Wang, and C.X. Huang. 2018. Effect of α7nAChR mediated cholinergic anti-inflammatory pathway on inhibition of atrial fibrillation by low-level vagus nerve stimulation. Zhonghua Yi Xue Za Zhi 98 (11): 855–859.PubMed

Jarczyk, J., B.A. Yard, and S. Hoeger. 2019. The cholinergic anti-inflammatory pathway as a conceptual framework to treat inflammation-mediated renal injury. Kidney & Blood Pressure Research 44 (4): 435–448.CrossRef

Li, Z., H. Hao, Y. Gao, Z. Wang, W. Lu, and J. Liu. 2019. Expression and localization analyses of the cholinergic anti-inflammatory pathway and α7nAchR in different tissues of rats with rheumatoid arthritis. Acta Histochemica 121 (6): 742–749.PubMedCrossRef

Tracey, K.J. 2002. The inflammatory reflex. Nature 420 (6917): 853–859.PubMedCrossRef

10.

Borovikova, L.V., S. Ivanova, M. Zhang, H. Yang, G.I. Botchkina, L.R. Watkins, H. Wang, N. Abumrad, J.W. Eaton, and K.J. Tracey. 2000. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (6785): 458–462.PubMedCrossRef

11.

van Westerloo, D.J., I.A. Giebelen, S. Florquin, J. Daalhuisen, M.J. Bruno, A.F. de Vos, K.J. Tracey, and T. van der Poll. 2005. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. The Journal of Infectious Diseases 191 (12): 2138–2148.PubMedCrossRef

12.

Ghia, J.E., P. Blennerhassett, and S.M. Collins. 2008. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. The Journal of Clinical Investigation 118 (6): 2209–2218.PubMedPubMedCentral

13.

Yeboah, M.M., X. Xue, B. Duan, M. Ochani, K.J. Tracey, M. Susin, and C.N. Metz. 2008. Cholinergic agonists attenuate renal ischemia-reperfusion injury in rats. Kidney International 74 (1): 62–69.PubMedPubMedCentralCrossRef

14.

Rosas-Ballina, M., M. Ochani, W.R. Parrish, K. Ochani, Y.T. Harris, J.M. Huston, S. Chavan, and K.J. Tracey. 2008. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proceedings of the National Academy of Sciences of the United States of America 105 (31): 11008–11013.PubMedPubMedCentralCrossRef

15.

Huston, J.M., M. Ochani, M. Rosas-Ballina, H. Liao, K. Ochani, V.A. Pavlov, M. Gallowitsch-Puerta, M. Ashok, C.J. Czura, B. Foxwell, K.J. Tracey, and L. Ulloa. 2006. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. The Journal of Experimental Medicine 203 (7): 1623–1628.PubMedPubMedCentralCrossRef

16.

Revathikumar, P., J. Estelius, U. Karmakar, E. Le Maître, M. Korotkova, P.J. Jakobsson, and J. Lampa. 2018. Microsomal prostaglandin E synthase-1 gene deletion impairs neuro-immune circuitry of the cholinergic anti-inflammatory pathway in endotoxaemic mouse spleen. PLoS One 13 (2): e0193210.PubMedPubMedCentralCrossRef

17.

Bellinger, D.L., S.Y. Felten, D. Lorton, and D.L. Felten. 1989. Origin of noradrenergic innervation of the spleen in rats. Brain, Behavior, and Immunity 3 (4): 291–311.PubMedCrossRef

18.

Bellinger, D.L., S.Y. Felten, T.J. Collier, and D.L. Felten. 1987. Noradrenergic sympathetic innervation of the spleen: IV. Morphometric analysis in adult and aged F344 rats. Journal of Neuroscience Research 18 (1): 55–63 126–129.PubMedCrossRef

19.

Martelli, D., M.J. McKinley, and R.M. McAllen. 2014. The cholinergic anti-inflammatory pathway: a critical review. Autonomic Neuroscience 182: 65–69.PubMedCrossRef

20.

Jensen, A.A., B. Frølund, T. Liljefors, and P. Krogsgaard-Larsen. 2005. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. Journal of Medicinal Chemistry 48 (15): 4705–4745.PubMedCrossRef

21.

Lukas, R.J., J.P. Changeux, N. Le Novère, E.X. Albuquerque, D.J. Balfour, D.K. Berg, D. Bertrand, V.A. Chiappinelli, P.B. Clarke, A.C. Collins, J.A. Dani, S.R. Grady, K.J. Kellar, J.M. Lindstrom, M.J. Marks, M. Quik, P.W. Taylor, and S. Wonnacott. 1999. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacological Reviews 51 (2): 397–401.PubMed

22.

Romanelli, M.N., and F. Gualtieri. 2003. Cholinergic nicotinic receptors: competitive ligands, allosteric modulators, and their potential applications. Medicinal Research Reviews 23 (4): 393–426.PubMedCrossRef

23.

Hurst, R., H. Rollema, and D. Bertrand. 2013. Nicotinic acetylcholine receptors: from basic science to therapeutics. Pharmacology & Therapeutics 137 (1): 22–54.CrossRef

24.

Gault, J., M. Robinson, R. Berger, C. Drebing, J. Logel, J. Hopkins, T. Moore, S. Jacobs, J. Meriwether, M.J. Choi, E.J. Kim, K. Walton, K. Buiting, A. Davis, C. Breese, R. Freedman, and S. Leonard. 1998. Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics 52 (2): 173–185.PubMedCrossRef

25.

Canastar, A., J. Logel, S. Graw, J. Finlay-Schultz, C. Osborne, M. Palionyte, C. Drebing, M. Plehaty, L. Wilson, R. Eyeson, and S. Leonard. 2012. Promoter methylation and tissue-specific transcription of the α7 nicotinic receptor gene, CHRNA7. Journal of Molecular Neuroscience 47 (2): 389–400.PubMedCrossRef

26.

Kombo, D.C., A.A. Mazurov, J. Chewning, P.S. Hammond, K. Tallapragada, T.A. Hauser, J. Speake, D. Yohannes, and W.S. Caldwell. 2012. Discovery of novel α7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogs. Bioorganic & Medicinal Chemistry Letters 22 (2): 1179–1186.CrossRef

27.

Wang, H.Y., D.H. Lee, M.R. D'Andrea, P.A. Peterson, R.P. Shank, and A.B. Reitz. 2000. beta-Amyloid (1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer’s disease pathology. The Journal of Biological Chemistry 275 (8): 5626–5632.PubMedCrossRef

28.

Burghaus, L., U. Schütz, U. Krempel, J. Lindstrom, and H. Schröder. 2003. Loss of nicotinic acetylcholine receptor subunits alpha4 and alpha7 in the cerebral cortex of Parkinson patients. Parkinsonism & Related Disorders 9 (5): 243–246.CrossRef

29.

Wang, H., M. Yu, M. Ochani, C.A. Amella, M. Tanovic, S. Susarla, J.H. Li, H. Wang, H. Yang, L. Ulloa, Y. Al-Abed, C.J. Czura, and K.J. Tracey. 2003. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421 (6921): 384–388.PubMedCrossRef

30.

Sinkus, M.L., S. Graw, R. Freedman, R.G. Ross, H.A. Lester, and S. Leonard. 2015. The human CHRNA7 and CHRFAM7A genes: a review of the genetics, regulation, and function. Neuropharmacology 96 (Pt B): 274–288.PubMedPubMedCentralCrossRef

31.

John, D., I. Shelukhina, Y. Yanagawa, J. Deuchars, and Z. Henderson. 2015. Functional alpha7 nicotinic receptors are expressed on immature granule cells of the postnatal dentate gyrus. Brain Research 1601: 15–30.PubMedPubMedCentralCrossRef

32.

Moretti, M., M. Zoli, A.A. George, R.J. Lukas, F. Pistillo, U. Maskos, P. Whiteaker, and C. Gotti. 2014. The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization. Molecular Pharmacology 86 (3): 306–317.PubMedPubMedCentralCrossRef

33.

Qi, X.L., and Z.Z. Guan. 2008. Neuroprotective effects of alpha7 neuronal acetylcholine receptor and its roles in the pathogenesis of Alzheimer’s disease. Zhong hua Bing Li Xue Za Zhi 37 (1): 51–55.

34.

Gotti, C., and F. Clementi. 2004. Neuronal nicotinic receptors: from structure to pathology. Progress in Neurobiology 74 (6): 363–396.PubMedCrossRef

35.

Chen, L.Y., Z.G. Liu, Y.H. Li, Y.Z. Feng, and J.R. Wang. 2008. Expression of neuronal acetylcholine receptor alpha 7 (nAChRalpha7) in peripheral blood CD(4)(+) T lymphocytes from asthmatic children. Zhong hua Jie He He Hu Xi Za Zhi 31 (11): 803–805.

36.

Blanchet, M.R., E. Israël-Assayag, P. Daleau, M.J. Beaulieu, and Y. Cormier. 2006. Dimethyphenylpiperazinium, a nicotinic receptor agonist, downregulates inflammation in monocytes/macrophages through PI3K and PLC chronic activation. American Journal of Physiology. Lung Cellular and Molecular Physiology 291 (4): L757–L763.PubMedCrossRef

37.

Villiger, Y., I. Szanto, S. Jaconi, C. Blanchet, B. Buisson, K.H. Krause, D. Bertrand, and J.A. Romand. 2002. Expression of an alpha7 duplicate nicotinic acetylcholine receptor-related protein in human leukocytes. Journal of Neuroimmunology 126 (1–2): 86–98.PubMedCrossRef

38.

Sugano, N., K. Shimada, K. Ito, and S. Murai. 1998. Nicotine inhibits the production of inflammatory mediators in U937 cells through modulation of nuclear factor-kappaB activation. Biochemical and Biophysical Research Communications 252 (1): 25–28.PubMedCrossRef

39.

Rioux, N., and A. Castonguay. 2000. The induction of cyclooxygenase-1 by a tobacco carcinogen in U937 human macrophages is correlated to the activation of NF-kappaB. Carcinogenesis 21 (9): 1745–1751.PubMedCrossRef

40.

Wang, H., H. Liao, M. Ochani, M. Justiniani, X. Lin, L. Yang, Y. Al-Abed, H. Wang, C. Metz, E.J. Miller, K.J. Tracey, and L. Ulloa. 2004. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nature Medicine 10 (11): 1216–1221.PubMedCrossRef

41.

Saeed, R.W., S. Varma, T. Peng-Nemeroff, B. Sherry, D. Balakhaneh, J. Huston, K.J. Tracey, Y. Al-Abed, and C.N. Metz. 2005. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. The Journal of Experimental Medicine 201 (7): 1113–11123.PubMedPubMedCentralCrossRef

42.

Tanaka, M., M.E. Fuentes, K. Yamaguchi, M.H. Durnin, S.A. Dalrymple, K.L. Hardy, and D.V. Goeddel. 1999. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 10 (4): 421–429.PubMedCrossRef

43.

van Maanen, M.A., M.C. Lebre, T. van der Poll, G.J. LaRosa, D. Elbaum, M.J. Vervoordeldonk, and P.P. Tak. 2009. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis and Rheumatism 60 (1): 114–122.PubMedCrossRef

44.

Navarro, E., I. Buendia, E. Parada, R. Leon, P. Jansen-Duerr, H. Pircher, J. Egea, and M.G. Lopez. 2015. Alpha7 nicotinic receptor activation protects against oxidative stress via heme-oxygenase I induction. Biochemical Pharmacology 97 (4): 473–481.PubMedCrossRef

45.

Patel, H., J. McIntire, S. Ryan, A. Dunah, and R. Loring. 2017. Anti-inflammatory effects of astroglial α7 nicotinic acetylcholine receptors are mediated by inhibition of the NF-κB pathway and activation of the Nrf2 pathway. Journal of Neuroinflammation 14 (1): 192.PubMedPubMedCentralCrossRef

46.

Rojo, A.I., G. McBean, M. Cindric, J. Egea, M.G. López, P. Rada, N. Zarkovic, and A. Cuadrado. 2014. Redox control of microglial function: molecular mechanisms and functional significance. Antioxidants & Redox Signaling 21 (12): 1766–1801.CrossRef

47.

de Jonge, W.J., E.P. van der Zanden, F.O. The, M.F. Bijlsma, D.J. van Westerloo, R.J. Bennink, H.R. Berthoud, S. Uematsu, S. Akira, R.M. van den Wijngaard, and G.E. Boeckxstaens. 2005. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nature Immunology 6 (8): 844–851.PubMedCrossRef

48.

Maldifassi, M.C., G. Atienza, F. Arnalich, E. López-Collazo, J.L. Cedillo, C. Martín-Sánchez, A. Bordas, J. Renart, and C. Montiel. 2014. A new IRAK-M-mediated mechanism implicated in the anti-inflammatory effect of nicotine via α7 nicotinic receptors in human macrophages. PLoS One 9 (9): e108397.PubMedPubMedCentralCrossRef

49.

Park, S.Y., Y.H. Baik, J.H. Cho, S. Kim, K.S. Lee, and J.S. Han. 2008. Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells. Cytokine 44 (1): 126–134.PubMedCrossRef

50.

Sun, Y., Q. Li, H. Gui, D.P. Xu, Y.L. Yang, D.F. Su, and X. Liu. 2013. MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell Research 23 (11): 1270–1283.PubMedPubMedCentralCrossRef

51.

Ulloa, L., J. Doody, and J. Massagué. 1999. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 397 (6721): 710–713.PubMedCrossRef

52.

Jenkins, B.J., D. Grail, T. Nheu, M. Najdovska, B. Wang, P. Waring, M. Inglese, R.M. McLoughlin, S.A. Jones, N. Topley, H. Baumann, L.M. Judd, A.S. Giraud, A. Boussioutas, H.J. Zhu, and M. Ernst. 2005. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Nature Medicine 11 (8): 845–852.PubMedCrossRef

53.

Yu, Z., W. Zhang, and B.C. Kone. 2002. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. The Biochemical Journal 367 (Pt 1): 97–105.PubMedPubMedCentralCrossRef

54.

Yu, Z., and B.C. Kone. 2004. The STAT3 DNA-binding domain mediates interaction with NF-kappaB p65 and inducible nitric oxide synthase transrepression in mesangial cells. Journals of the American Society of Nephrology 15 (3): 585–591.CrossRef

55.

Hoentjen, F., R.B. Sartor, M. Ozaki, and C. Jobin. 2005. STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. Blood 105 (2): 689–696.PubMedCrossRef

56.

Arredondo, J., A.I. Chernyavsky, D.L. Jolkovsky, K.E. Pinkerton, and S.A. Grando. 2006. Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes. The FASEB Journal 20 (12): 2093–2101.PubMedCrossRef

57.

Hamano, R., H.K. Takahashi, H. Iwagaki, T. Yoshino, M. Nishibori, and N. Tanaka. 2006. Stimulation of alpha7 nicotinic acetylcholine receptor inhibits CD14 and the toll-like receptor 4 expression in human monocytes. Shock 26 (4): 358–364.PubMedCrossRef

58.

Heeschen, C., J.J. Jang, M. Weis, A. Pathak, S. Kaji, R.S. Hu, P.S. Tsao, F.L. Johnson, and J.P. Cooke. 2001. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nature Medicine 7 (7): 833–839.PubMedCrossRef

59.

Takahashi, H.K., H. Iwagaki, R. Hamano, T. Yoshino, N. Tanaka, and M. Nishibori. 2006. alpha7 Nicotinic acetylcholine receptor stimulation inhibits lipopolysaccharide-induced interleukin-18 and -12 production in monocytes. Journal of Pharmacological Sciences 102 (1): 143–146.PubMedCrossRef

60.

Zabrodskiĭ, P.F. 1987. Effect of armin on nonspecific resistance factors of the body and on the primary humoral immune response. Farmakologiia i Toksikologiia 50 (1): 57–60.PubMed

61.

Cope, A.P., H. Schulze-Koops, and M. Aringer. 2007. The central role of T cells in rheumatoid arthritis. Clinical and Experimental Rheumatology 25 (5 Suppl 46): S4–S11.PubMed

62.

Mellado, M., L. Martínez-Muñoz, G. Cascio, P. Lucas, J.L. Pablos, and J.M. Rodríguez-Frade. 2015. T Cell Migration in Rheumatoid Arthritis. Frontiers in Immunology 6: 384.PubMedPubMedCentralCrossRef

63.

Schwaneck, E.C., R. Renner, L. Junker, H.P. Tony, S. Kleinert, M. Gernert, M. Schmalzing, and O. Gadeholt. 2020. T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy. Scandinavian Journal of Rheumatology 49 (1): 8–12.PubMedCrossRef

64.

Nizri, E., Y. Hamra-Amitay, C. Sicsic, I. Lavon, and T. Brenner. 2006. Anti-inflammatory properties of cholinergic up-regulation: a new role for acetylcholinesterase inhibitors. Neuropharmacology 50 (5): 540–547.PubMedCrossRef

65.

Nizri, E., M. Irony-Tur-Sinai, N. Faranesh, I. Lavon, E. Lavi, M. Weinstock, and T. Brenner. 2008. Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine. Journal of Neuroimmunology 203 (1): 12–22.PubMedCrossRef

66.

Nizri, E., M. Irony-Tur-Sinai, O. Lory, A. Orr-Urtreger, E. Lavi, and T. Brenner. 2009. Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. Journal of Immunology 183 (10): 6681–6688.CrossRef

67.

Nizri, E., M. Irony-Tur-Sinai, I. Lavon, H. Meshulam, G. Amitai, and T. Brenner. 2007. IBU-octyl-cytisine, a novel bifunctional compound eliciting anti-inflammatory and cholinergic activity, ameliorates CNS inflammation by inhibition of T-cell activity. International Immunopharmacology 7 (9): 1129–1139.PubMedCrossRef

68.

Tjiu, J.W., P.J. Lin, W.H. Wu, Y.P. Cheng, H.C. Chiu, H.Y. Thong, B.L. Chiang, W.S. Yang, and S.H. Jee. 2011. SLURP1 mutation-impaired T-cell activation in a family with mal de Meleda. The British Journal of Dermatology 164 (1): 47–53.PubMedCrossRef

69.

Lina, C., W. Conghua, L. Nan, and Z. Ping. 2011. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis. Journal of Clinical Immunology 31 (4): 596–605.PubMedCrossRef

70.

Talaat, R.M., S.F. Mohamed, I.H. Bassyouni, and A.A. Raouf. 2015. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity. Cytokine 72 (2): 146–153.PubMedCrossRef

71.

Astry, B., S.H. Venkatesha, and K.D. Moudgil. 2015. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis. Cytokine 74 (1): 54–61.PubMedPubMedCentralCrossRef

72.

Galitovskiy, V., J. Qian, A.I. Chernyavsky, S. Marchenko, V. Gindi, R.A. Edwards, and S.A. Grando. 2011. Cytokine-induced alterations of α7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis. Journal of Immunology 187 (5): 2677–2687.CrossRef

73.

Gowayed, M.A., K. Rothe, M. Rossol, A.S. Attia, U. Wagner, C. Baerwald, H.S. El-Abhar, and R. Refaat. 2019. The role of α7nAChR in controlling the anti-inflammatory/anti-arthritic action of galantamine. Biochemical Pharmacology 170: 113665.PubMedCrossRef

74.

Munyaka, P., M.F. Rabbi, V.A. Pavlov, K.J. Tracey, E. Khafipour, and J.E. Ghia. 2014. Central muscarinic cholinergic activation alters interaction between splenic dendritic cell and CD4+CD25- T cells in experimental colitis. PLoS One 9 (10): e109272.PubMedPubMedCentralCrossRef

75.

Ren, C., X.H. Li, S.B. Wang, L.X. Wang, N. Dong, Y. Wu, and Y.M. Yao. 2018. Activation of central alpha 7 nicotinic acetylcholine receptor reverses suppressed immune function of T lymphocytes and protects against sepsis lethality. International Journal of Biological Sciences 14 (7): 748–759.PubMedPubMedCentralCrossRef

76.

Wu, S., H. Zhao, H. Luo, X. Xiao, H. Zhang, T. Li, and X. Zuo. 2014. GTS-21, an α7-nicotinic acetylcholine receptor agonist, modulates Th1 differentiation in CD4(+) T cells from patients with rheumatoid arthritis. Experimental and Therapeutic Medicine 8 (2): 557–562.PubMedPubMedCentralCrossRef

77.

Kondo, M. 2010. Lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors. Immunological Reviews 238 (1): 37–46.PubMedPubMedCentralCrossRef

78.

Kambayashi, T., and T.M. Laufer. 2014. Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? Nature Reviews. Immunology 14 (11): 719–730.PubMedCrossRef

79.

Fields, M.L., and J. Erikson. 2003. The regulation of lupus-associated autoantibodies: immunoglobulin transgenic models. Current Opinion in Immunology 15 (6): 709–717.PubMedCrossRef

80.

Hasan, M., G. Lopez-Herrera, K.E. Blomberg, J.M. Lindvall, A. Berglöf, C.I. Smith, and L. Vargas. 2008. Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton’s tyrosine kinase-deficient mice. Immunology 123 (2): 239–249.PubMedPubMedCentral

81.

Kawashima, K., and T. Fujii. 2004. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Frontiers in Bioscience 9: 2063–2085.PubMedCrossRef

82.

Kimura, R., N. Ushiyama, T. Fujii, and K. Kawashima. 2003. Nicotine-induced Ca2+ signaling and down-regulation of nicotinic acetylcholine receptor subunit expression in the CEM human leukemic T-cell line. Life Sciences 72 (18–19): 2155–2158.PubMedCrossRef

83.

Skok, M., R. Grailhe, F. Agenes, and J.P. Changeux. 2006. The role of nicotinic acetylcholine receptors in lymphocyte development. Journal of Neuroimmunology 171 (1–2): 86–98.PubMedCrossRef

84.

Nizri, E., and T. Brenner. 2013. Modulation of inflammatory pathways by the immune cholinergic system. Amino Acids 45 (1): 73–85.PubMedCrossRef

85.

Skok, M.V., E.N. Kalashnik, L.N. Koval, V.I. Tsetlin, Y.N. Utkin, J.P. Changeux, and R. Grailhe. 2003. Functional nicotinic acetylcholine receptors are expressed in B lymphocyte-derived cell lines. Molecular Pharmacology 64 (4): 885–889.PubMedCrossRef

86.

Koval, L.M., O. Yu Lykhmus, D.M. Omelchenko, S.V. Komisarenko, and M.V. Skok. 2009. The role of alpha7 nicotinic acetylcholine receptors in B lymphocyte activation. Ukr Biokhim Zh (1999) 81 (4): 5–11.

87.

Quezada, S.A., L.Z. Jarvinen, E.F. Lind, and R.J. Noelle. 2004. CD40/CD154 interactions at the interface of tolerance and immunity. Annual Review of Immunology 22: 307–328.PubMedCrossRef

88.

Hecker, A., Z. Mikulski, K.S. Lips, U. Pfeil, A. Zakrzewicz, S. Wilker, P. Hartmann, W. Padberg, I. Wessler, W. Kummer, and V. Grau. 2009. Pivotal Advance: Up-regulation of acetylcholine synthesis and paracrine cholinergic signaling in intravascular transplant leukocytes during rejection of rat renal allografts. Journal of Leukocyte Biology 86 (1): 13–22.PubMedCrossRef

89.

Skok, M., R. Grailhe, and J.P. Changeux. 2005. Nicotinic receptors regulate B lymphocyte activation and immune response. European Journal of Pharmacology 517 (3): 246–251.PubMedCrossRef

90.

Fujii, Y.X., H. Fujigaya, Y. Moriwaki, H. Misawa, T. Kasahara, S.A. Grando, and K. Kawashima. 2007. Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. Journal of Neuroimmunology 189 (1–2): 69–74.PubMedCrossRef

91.

Gordon, S., and P.R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nature Reviews Immunology 5 (12): 953–964.PubMedCrossRef

92.

Ouchi, N., S. Kihara, T. Funahashi, Y. Matsuzawa, and K. Walsh. 2003. Obesity, adiponectin and vascular inflammatory disease. Current Opinion in Lipidology 14 (6): 561–566.PubMedCrossRef

93.

Tobias, P., and L.K. Curtiss. 2005. Thematic review series: the immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis. Journal of Lipid Research 46 (3): 404–411.PubMedCrossRef

94.

Zhang, L., and C.C. Wang. 2014. Inflammatory response of macrophages in infection. Hepatobiliary & Pancreatic Diseases International 13 (2): 138–152.CrossRef

95.

Kong, X., and J. Gao. 2017. Macrophage polarization: a key event in the secondary phase of acute spinal cord injury. Journal of Cellular and Molecular Medicine 21 (5): 941–954.PubMedCrossRef

96.

Ambarus, C.A., T. Noordenbos, M.J. de Hair, P.P. Tak, and D.L. Baeten. 2012. Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis. Arthritis Research and Therapy 14 (2): R74.PubMedCrossRef

97.

Lv, Y., S. Hu, J. Lu, N. Dong, Q. Liu, M. Du, and H. Zhang. 2014. Upregulating nonneuronal cholinergic activity decreases TNF release from lipopolysaccharide-stimulated RAW264.7 cells. Mediators of Inflammation 2014: 873728.PubMedPubMedCentralCrossRef

98.

Chernyavsky, A.I., J. Arredondo, M. Skok, and S.A. Grando. 2010. Auto/paracrine control of inflammatory cytokines by acetylcholine in macrophage-like U937 cells through nicotinic receptors. International Immunopharmacology 10 (3): 308–315.PubMedCrossRef

99.

Rosas-Ballina, M., R.S. Goldstein, M. Gallowitsch-Puerta, L. Yang, S.I. Valdés-Ferrer, N.B. Patel, S. Chavan, Y. Al-Abed, H. Yang, and K.J. Tracey. 2009. The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. Molecular Medicine 15 (7–8): 195–202.PubMedPubMedCentralCrossRef

100.

Lotze, M.T., and K.J. Tracey. 2005. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nature Reviews Immunology 5 (4): 331–342.PubMedCrossRef

101.

Ulleryd, M.A., F. Mjörnstedt, D. Panagaki, L.J. Yang, K. Engevall, S. Gutiérrez, Y. Wang, L.M. Gan, H. Nilsson, E. Michaëlsson, and M.E. Johansson. 2019. Stimulation of alpha 7 nicotinic acetylcholine receptor (α7nAChR) inhibits atherosclerosis via immunomodulatory effects on myeloid cells. Atherosclerosis 287: 122–133.PubMedCrossRef

102.

van der Zanden, E.P., S.A. Snoek, S.E. Heinsbroek, O.I. Stanisor, C. Verseijden, G.E. Boeckxstaens, M.P. Peppelenbosch, D.R. Greaves, S. Gordon, and W.J. De Jonge. 2009. Vagus nerve activity augments intestinal macrophage phagocytosis via nicotinic acetylcholine receptor alpha4beta2. Gastroenterology 137 (3): 1029–1039 e10394.PubMedCrossRef

103.

Pinheiro, N.M., F.P. Santana, R.R. Almeida, M. Guerreiro, M.A. Martins, L.C. Caperuto, N.O. Câmara, L.A. Wensing, V.F. Prado, I.F. Tibério, M.A. Prado, and C.M. Prado. 2017. Acute lung injury is reduced by the α7nAChR agonist PNU-282987 through changes in the macrophage profile. The FASEB Journal 31 (1): 320–332.PubMedCrossRef

104.

Wang, J., R. Li, Z. Peng, W. Zhou, B. Hu, X. Rao, X. Yang, and J. Li. 2019. GTS-21 reduces inflammation in acute lung injury by regulating M1 polarization and function of alveolar macrophages. Shock 51 (3): 389–400.PubMedCrossRef

105.

Wilund, K.R., M. Rosenblat, H.R. Chung, N. Volkova, M. Kaplan, J.A. Woods, and M. Aviram. 2009. Macrophages from alpha 7 nicotinic acetylcholine receptor knockout mice demonstrate increased cholesterol accumulation and decreased cellular paraoxonase expression: a possible link between the nervous system and atherosclerosis development. Biochemical and Biophysical Research Communications 390 (1): 148–154.PubMedCrossRef

106.

Inoue, T., C. Abe, T. Kohro, S. Tanaka, L. Huang, J. Yao, S. Zheng, H. Ye, R. Inagi, R.L. Stornetta, D.L. Rosin, M. Nangaku, Y. Wada, and M.D. Okusa. 2019. Non-canonical cholinergic anti-inflammatory pathway-mediated activation of peritoneal macrophages induces Hes1 and blocks ischemia/reperfusion injury in the kidney. Kidney International 95 (3): 563–576.PubMedPubMedCentralCrossRef

107.

Lin, W., T. Liu, B. Wang, and H. Bi. 2019. The role of ocular dendritic cells in uveitis. Immunology Letters 209: 4–10.PubMedCrossRef

108.

Chudnovskiy, A., G. Pasqual, and G.D. Victora. 2019. Studying interactions between dendritic cells and T cells in vivo. Current Opinion in Immunology 58: 24–30.PubMedPubMedCentralCrossRef

109.

Ganguly, D., S. Haak, V. Sisirak, and B. Reizis. 2013. The role of dendritic cells in autoimmunity. Nature Reviews Immunology 13 (8): 566–577.PubMedPubMedCentralCrossRef

110.

Aicher, A., C. Heeschen, M. Mohaupt, J.P. Cooke, A.M. Zeiher, and S. Dimmeler. 2003. Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions. Circulation 107 (4): 604–611.PubMedCrossRef

111.

Nouri-Shirazi, M., and E. Guinet. 2003. Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology 109 (3): 365–373.PubMedPubMedCentralCrossRef

112.

Guinet, E., K. Yoshida, and M. Nouri-Shirazi. 2004. Nicotinic environment affects the differentiation and functional maturation of monocytes derived dendritic cells (DCs). Immunology Letters 95 (1): 45–55.PubMedCrossRef

113.

Yanagita, M., K. Mori, R. Kobayashi, Y. Kojima, M. Kubota, K. Miki, S. Yamada, M. Kitamura, and S. Murakami. 2012. Immunomodulation of dendritic cells differentiated in the presence of nicotine with lipopolysaccharide from Porphyromonas gingivalis. European Journal of Oral Sciences 120 (5): 408–414.PubMedCrossRef

114.

Gori, S., M. Vermeulen, F. Remes-Lenicov, C. Jancic, W. Scordo, A. Ceballos, N. Towstyka, Y. Bestach, C. Belli, and F. Sabbione. 2017. Acetylcholine polarizes dendritic cells toward a Th2-promoting profile. Allergy 72 (2): 221–231.PubMedCrossRef

115.

Seyler, L.E., J. Fertig, O. Pomerleau, D. Hunt, and K. Parker. 1984. The effects of smoking on ACTH and cortisol secretion. Life Sciences 34 (1): 57–65.PubMedCrossRef

116.

Michell-Robinson, M.A., H. Touil, L.M. Healy, D.R. Owen, B.A. Durafourt, A. Bar-Or, J.P. Antel, and C.S. Moore. 2015. Roles of microglia in brain development, tissue maintenance and repair. Brain 138 (Pt 5): 1138–1159.PubMedPubMedCentralCrossRef

117.

Shytle, R.D., T. Mori, K. Townsend, M. Vendrame, N. Sun, J. Zeng, J. Ehrhart, A.A. Silver, P.R. Sanberg, and J. Tan. 2004. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. Journal of Neurochemistry 89 (2): 337–343.PubMedCrossRef

118.

Tsuda, M. 2018. Modulation of pain and itch by spinal glia. Neuroscience Bulletin 34 (1): 178–185.PubMedCrossRef

119.

Suzuki, T., I. Hide, A. Matsubara, C. Hama, K. Harada, K. Miyano, M. Andrä, H. Matsubayashi, N. Sakai, S. Kohsaka, K. Inoue, and Y. Nakata. 2006. Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role. Journal of Neuroscience Research 83 (8): 1461–1470.PubMedCrossRef

120.

Polazzi, E., and B. Monti. 2010. Microglia and neuroprotection: from in vitro studies to therapeutic applications. Progress in Neurobiology 92 (3): 293–315.PubMedCrossRef

121.

Zhang, J., and S. Rivest. 2001. Anti-inflammatory effects of prostaglandin E2 in the central nervous system in response to brain injury and circulating lipopolysaccharide. Journal of Neurochemistry 76 (3): 855–864.PubMedCrossRef

122.

Egea, J., I. Buendia, E. Parada, E. Navarro, R. León, and M.G. Lopez. 2015. Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection. Biochemical Pharmacology 97 (4): 463–472.PubMedCrossRef

123.

Noda, M., and A.I. Kobayashi. 2017. Nicotine inhibits activation of microglial proton currents via interactions with α7 acetylcholine receptors. The Journal of Physiological Sciences 67 (1): 235–245.PubMedCrossRef

124.

Morioka, N., S. Harano, M. Tokuhara, Y. Idenoshita, F.F. Zhang, K. Hisaoka-Nakashima, and Y. Nakata. 2015. Stimulation of α7 nicotinic acetylcholine receptor regulates glutamate transporter GLAST via basic fibroblast growth factor production in cultured cortical microglia. Brain Research 1625: 111–120.PubMedCrossRef

125.

Parada, E., J. Egea, I. Buendia, P. Negredo, A.C. Cunha, S. Cardoso, M.P. Soares, and M.G. López. 2013. The microglial α7-acetylcholine nicotinic receptor is a key element in promoting neuroprotection by inducing heme oxygenase-1 via nuclear factor erythroid-2-related factor 2. Antioxidants and Redox Signaling 19 (11): 1135–1148.PubMedCrossRef

126.

Toyohara, J., and K. Hashimoto. 2010. α7 nicotinic receptor agonists: potential therapeutic drugs for treatment of cognitive impairments in schizophrenia and Alzheimer’s disease. Open Medicinal Chemistry Journal 4: 37–56.

127.

Borovikova, L.V., S. Ivanova, D. Nardi, M. Zhang, H. Yang, M. Ombrellino, and K.J. Tracey. 2000. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Autonomic Neuroscience 85 (1–3): 141–147.PubMedCrossRef

128.

Faghih, R., M. Gopalakrishnan, and C.A. Briggs. 2008. Allosteric modulators of the alpha7 nicotinic acetylcholine receptor. Journal of Medicinal Chemistry 51 (4): 701–712.PubMedCrossRef

129.

Bouzat, C., M. Lasala, B.E. Nielsen, J. Corradi, and M.D.C. Esandi. 2018. Molecular function of α7 nicotinic receptors as drug targets. The Journal of Physiology 596 (10): 1847–1861.PubMedCrossRef

Titel: The Role of α7nAChR-Mediated Cholinergic Anti-inflammatory Pathway in Immune Cells
verfasst von: Yi-jin Wu
Li Wang
Chao-fan Ji
Shao-fei Gu
Qin Yin
Jian Zuo
Publikationsdatum: 06.01.2021
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 3/2021
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-020-01396-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

The Association Between β-Dystroglycan in Airway Smooth Muscle and Eosinophils in Allergic Asthma

MiR-708-3p Alleviates Inflammation and Myocardial Injury After Myocardial Infarction by Suppressing ADAM17 Expression

TRIM Proteins in Inflammation: from Expression to Emerging Regulatory Mechanisms

Tadalafil Alleviates LPS-Induced Inflammation and Oxidative Stress of RWPE-1 Cell by Regulating the Akt/Nrf2 Signaling Pathway

Amelioration of Juglanin against LPS-Induced Activation of NLRP3 Inflammasome in Chondrocytes Mediated by SIRT1